GL1X · GenesisL1 explorer

Research workbench

Inhibitor induced structural change in the HCV ires domain iia RNA

Analyse Inhibitor induced structural change in the HCV ires domain iia RNA in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2KTZ
Type
RNA
Length
38 nucleotides
Chains
1
Method
solution nmr
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HCV ires domain iia RNA
Ligands
ISH
Pockets
2 · best druggability 0.45

Structure

solution nmr · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
AHCV ires domain iia RNArna38——

Ligands and binding sites

  • ISH · (7R)-7-[(dimethylamino)methyl]-1-[3-(dimethylamino)propyl]-7,8-dihydro-1H-furo[3,2-e]benzimidazol-2-amine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12610.450.7222empty
2620.260.7310ISH

Compared structures

  • 2KTZ · Inhibitor Induced Structural Change in the HCV IRES Domain IIa RNA · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.